skip to main content

ProfessionalsAnya Richter Hodes

Anya Richter Hodes
Counsel

Tel: +1-212-373-3951
Fax: +1-212-492-0951
ahodes@paulweiss.com

Tel: +1-212-373-3951
ahodes@paulweiss.com
New York

1285 Avenue of the Americas
New York, NY 10019-6064
Fax: +1-212-492-0951

+ vCard ADD TO CONTACTS
Education 
Bar Admissions 
Education 
Bar Admissions 

Anya Richter Hodes is counsel in the Corporate Department and a member of the firm’s Mergers & Acquisitions Group. She advises on mergers and acquisitions, carve-outs, tender and exchange offers, joint ventures and other significant transactions for a diverse range of clients, including public and private companies, private equity funds and financial institutions. Anya’s practice also includes advising clients on corporate governance and activist defense matters.

EXPERIENCE

Anya’s recent representations have included:

  • A. Schulman in its $2.25 billion sale to LyondellBasell N.V.
  • Abaco Systems, a portfolio company of Veritas Capital, in its $1.35 billion sale to AMETEK
  • AEP Industries in its sale to Berry Plastics Group, Inc.
  • American Capital in its $3.4 billion sale to Ares Capital Corporation
  • Anaplan in its $10.7 billion sale to Thoma Bravo
  • BridgeBio Pharma in its $1 billion acquisition of the remaining 36% stake in Eidos Therapeutics that it did not already own
  • Brookfield Infrastructure Partners in its $13.3 billion acquisition of Triton International
  • Crown Castle in the proxy contest against Boots Capital Management
  • Five Star Holdings in its sale to The Jordan Company
  • Fortress Value Acquisition Corp. II in its $2.5 billion merger with ATI Physical Therapy
  • H.I.G. Bayside Capital in the sale of its portfolio company, Jackson Hewitt Tax Service, to Corsair Capital
  • IAC/InterActiveCorp in its acquisition of Care.com
  • Kemet Corporation in its $1.8 billion sale to Yageo Corporation
  • The board of directors of KKR & Co. in a series of structural and governance changes in connection with founders Henry Kravis and George Roberts stepping down as co-CEOs
  • The special committee of the board of directors of Myovant Sciences in the $1.7 billion sale to Sumitovant Biopharma of the remaining 48% stake in Myovant that Sumitovant did not already own
  • Navient Corporation in numerous transactions, including its evaluation and rejection of a $3.2 billion unsolicited acquisition proposal from Canyon Capital and Platinum Equity, and in connection with a threatened proxy contest by Canyon Capital and subsequent negotiation of a settlement agreement
  • Norfolk Southern in connection with a hostile takeover bid and proxy contest by Canadian Pacific Railway
  • Rithm Capital in its $1.5 billion acquisition of Genesis Capital and certain loan assets from Goldman Sachs Bank
  • Tricon Residential in its $3.5 billion take-private sale to Blackstone Real Estate Partners X and Blackstone Real Estate Income Trust
  • Veritas Capital in its $3 billion acquisition of Cubic Corporation

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy